Nimodipine variability in aneurysmal subarachnoid hemorrhage
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at how nimodipine, a medicine used to prevent blood vessel spasms after a brain bleed, works in people with aneurysmal subarachnoid hemorrhage. It aims to better understand how the drug behaves in your body, which could help improve treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old
- You have been diagnosed with a brain bleed caused by an aneurysm
- You are being treated with the drug nimodipine
- You have a catheter (thin tube) in a blood vessel for testing
- You arrived at the hospital within 96 hours (4 days) of your symptoms starting
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a spinal fluid (CSF) treatment to help prevent dangerous blood-vessel tightening (vasospasm) after a type of brain bleed caused by an aneurysm. If you qualify, the goal is to reduce complications soon after aneurysm repair.
This trial looks at tiny particles in the blood called extracellular vesicles to see how they differ in patients with brain aneurysms. It may help doctors better understand these aneurysms and improve treatment.
This study tests a treatment for people who have had a brain bleed (subarachnoid hemorrhage) and are at risk for delayed brain damage due to narrowed blood vessels. It looks at whether a special procedure to relax the vessels (spasmolysis) combined with raising blood pressure can prevent long-term harm.
This trial tests a safe, non-invasive treatment called remote ischemic conditioning (using a blood pressure cuff on your leg) to see if it helps brain recovery after aneurysm surgery. It might reduce secondary damage and improve outcomes.
This trial tests an endovascular procedure (a minimally invasive catheter-based treatment delivered through blood vessels) combined with a heart medication called milrinone to treat cerebral vasospasm—dangerous blood vessel narrowing that can occur after a ruptured brain aneurysm. The goal is to improve neurological recovery and prevent stroke.
This trial uses brain MRI scans and memory/brain-function tests in people who are recovering from a specific type of brain bleed (aneurysmal subarachnoid hemorrhage). It aims to understand how the brain’s memory area changes after the event and how that may relate to memory function during rehabilitation.
Hear when a new Subarachnoid Aneurysm Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.